Hi Stirer , that’s interesting , you think it’s to boost future cash flows by expanding production. I could probably see this point of view if they were currently selling all they currently produce, but it seems a bit premature at this stage to me with them still ramping up to planned capacity and sales below current production, though obviously you have a different opinion. To me it reads more like a short term injection of $2m to ensure project has sufficient cash.
- Forums
- ASX - By Stock
- WKT
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-148
-
-
- There are more pages in this discussion • 290 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WKT (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $63.76M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WKT (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online